causal

Bayh-Dole Act Ended Pharma Basic Research

Since the 1980 Bayh-Dole Act let universities and the NIH patent publicly funded discoveries and license them exclusively to big drug companies for royalties, pharmaceutical firms no longer need to do their own innovative basic research and instead license or buy early discoveries, leaving them only the expensive but non-innovative late-stage clinical development.

causalpending

Speaker

Marcia Angell

Evidence Quote

“the drug companies no longer have to do their own basic research. That's the creative part. That's the innovative part. They can license in or buy from startup companies... And then all they have to do is the late development. And that's the clinical trials.”

Source

Marcia Angell on Big Pharma— EconTalk
Created: 6/13/2026, 12:08:22 AM

Your notes

Loading notes...